DOJ Takes Aim At Actavis' Drug-Making Practices
The U.S. Department of Justice has targeted two U.S. subsidiaries of Iceland-based generic-drug maker Actavis Group in a suit alleging that a series of regulatory inspections have turned up problems with...To view the full article, register now.
Already a subscriber? Click here to view full article